Factors affecting the termination of cardiovascular actions of 10, 10-difluoro, 13-dehydroprostacyclin
References (12)
- et al.
Chemical stability of prostacyclin (PGI2) in aqueous solutions
Prostaglandins
(1978) - et al.
dl-9a-methylene PGI2 (A stable prostacyclin derivative): Preliminary pharmacological data
Prostagland. Med.
(1980) - et al.
Some biological activities of 10, 10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets
Thrombisis Res.
(1981) - et al.
Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets
J. Biol. Chem.
(1980) - et al.
An enzyme isolated from arteries transforms prostaglandin end operoxides to an unstable substance that inhibits platelet aggregation
Nature (London)
(1976) - et al.
Recirculation of prostacyclin (PGI2) in the dog
Br. J. Pharmacol.
(1980)
There are more references available in the full text version of this article.
Cited by (2)
Synthetic prostanoids (from CIRCA 1976)
2017, CRC Handbook of Eicosanoids: Prostaglandins and Related Lipids: Volume I: Chemical and Biochemical Aspects, Part BProstacyclinanalogs
1985, Medicinal Research Reviews
Copyright © 1983 Published by Elsevier Inc.